Disease development was accompanied with de novo transcription, as well as protein synthesis of BCR/ABL in vivo, demonstrating that the transfer of the Bcr/Abl gene from CML-derived EV to neutrophils may promote in vivo transformation of normal cells [39]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.